EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Markus Linder, Elisabeth Glitzner, Sriram Srivatsa, Latifa Bakiri, Kazuhiko Matsuoka, Parastoo Shahrouzi, Monika Dumanic, Philipp Novoszel, Thomas Mohr, Oliver Langer, Thomas Wanek, Markus Mitterhauser, Erwin F Wagner, Maria Sibilia

Journal title: EMBO Molecular Medicine

Journal number: 10/11

Journal publisher: John Wiley & Sons Ltd.

Published year: 2018

Published pages: e9408

DOI identifier: 10.15252/emmm.201809408

ISSN: 1757-4676